Top Story

Orphan drug shows promise in Prader-Willi syndrome

March 28, 2015

Ten weeks of therapy with a diazoxide choline controlled-release tablet appeared to help control hyperphagia and reduce antisocial behaviors associated with Prader-Willi syndrome, according to a press release from the drug’s developer, Essentialis, Inc.

Diazoxide choline was granted orphan status for the treatment of Prader-Willi syndrome (PWS) by the FDA in May of last year.

In the Journals

HT may reduce mortality risk in statin-treated postmenopausal women

March 20, 2015
In women treated with statins, hormone therapy appears to decrease the risk for death from any cause, according to research published in Menopause. Although lifestyle…
In the Journals

Oral melatonin may benefit sleep-deprived ICU patients

March 20, 2015
Melatonin could offer more and better quality sleep compared with earplugs and eye masks after exposure to environments with high levels of noise and light, according to…
Henry Boardman In the Journals

Hormone therapy offers no CV protection for postmenopausal women, may increase stroke risk

March 13, 2015
Hormone replacement therapy does not protect postmenopausal women against cardiovascular disease and may increase their risk for stroke and venous thromboembolic events…
More News Headlines »
Current Issues
View the Current Issues
morganatic-roan